Sterile Injectable Manufacturing: SOP for Sampling Procedures during Manufacturing – V 2.0
Standard Operating Procedure for Sampling Procedures during Manufacturing
| Department |
Sterile Injectable Manufacturing |
| SOP No. |
SOP/SIM/074/2025 |
| Supersedes |
SOP/SIM/074/2022 |
| Page No. |
Page 1 of 13 |
| Issue Date |
18/06/2025 |
| Effective Date |
20/06/2025 |
| Review Date |
18/06/2026 |
1. Purpose
To establish a standardized method for the collection of representative samples during various stages of sterile injectable manufacturing for testing and evaluation, ensuring regulatory compliance and product quality.
2. Scope
This SOP applies to all sterile injectable manufacturing activities at [Insert Company Name] where in-process, intermediate, and finished product
samples are collected for analysis and quality evaluation.
3. Responsibilities
- Production Officer: Responsible for collecting samples as per defined plan.
- IPQA Officer: Verifies correct sampling, labels, and documentation.
- QC Analyst: Receives samples and performs required tests.
4. Accountability
The Head – Quality Assurance is accountable for overall compliance and ensuring sampling procedures are followed during manufacturing operations.
5. Procedure
5.1 Sampling Plan
- Sampling must be performed based on approved sampling plan and batch manufacturing record (BMR).
- Sampling stages may include:
- Raw material sampling
- In-process bulk sampling
- Post-filtration sample
- Finished product sample
- Environmental and rinse water sample
5.2 Sample Collection Procedure
- Ensure clean and sterile containers for sample collection.
- Use sterile tools (pipettes, sampling needles) and handle with gloves.
- Label each sample immediately with:
- Batch No.
- Sample Type
- Date/Time
- Sampler Name
- Enter sample details in the Sampling Logbook (Annexure-1).
- Transfer the samples promptly to the Quality Control laboratory.
5.3 Sample Labeling
- Use pre-printed or computer-generated labels where applicable.
- Ensure clear legibility and tamper-evident labeling.
5.4 Sampling Precautions
- Do not sample from damaged or leaking containers/vials.
- Ensure aseptic techniques are used during all sampling.
- Avoid cross-contamination between samples.
5.5 Sample Quantities
- Follow BMR or SOP-defined quantity for each sample type.
- Minimum quantity must be sufficient for complete testing and retention sample (if applicable).
5.6 Documentation
- All samples must be recorded in the Sampling Logbook and annexure forms.
- Details to be entered include:
- Date and Time
- Sampler Name
- Batch and Sample Details
6. Abbreviations
- SOP: Standard Operating Procedure
- IPQA: In-Process Quality Assurance
- QC: Quality Control
- BMR: Batch Manufacturing Record
7. Documents
- Sampling Logbook – Annexure-1
- Sample Label Template – Annexure-2
- Sample Transfer Form – Annexure-3
8. References
- WHO TRS 986 Annex 2: GMP for Sterile Products
- ICH Q7: GMP for Active Pharmaceutical Ingredients
- 21 CFR Part 211 – Current Good Manufacturing Practice
9. SOP Version
Version: 2.0
10. Approval Section
|
Prepared By |
Checked By |
Approved By |
| Signature |
|
|
|
| Date |
|
|
|
| Name |
|
|
|
| Designation |
Manufacturing Executive |
QA Executive |
Head QA |
| Department |
Production |
Quality Assurance |
Quality Assurance |
11. Annexures
Annexure-1: Sampling Logbook
| Date |
Batch No. |
Sample Type |
Quantity |
Sampler Name |
Remarks |
| 18/06/2025 |
INJ-BT-3021 |
In-process |
20 mL |
Rajesh Kumar |
Complies |
Annexure-2: Sample Label Template
| Label Field |
Example Entry |
| Sample Type |
Bulk Solution |
| Batch No. |
INJ-BT-3021 |
| Date |
18/06/2025 |
| Sampler |
Sunita Reddy |
Annexure-3: Sample Transfer Form
| Date |
Sample Type |
Transferred By |
Received By |
QC Comments |
| 18/06/2025 |
Post-filtration |
Rajesh Kumar |
Vinay Pawar |
Accepted |
Revision History
| Revision Date |
Revision No. |
Details |
Reason |
Approved By |
| 01/01/2022 |
1.0 |
Initial Issue |
New SOP |
QA Head |
| 18/06/2025 |
2.0 |
Updated documentation and annexures |
Periodic Review |
QA Head |